• Home
  • Call
  • Innovative Medicine Initiative Call 13

Innovative Medicine Initiative Call 13

November 30, 2017 Written by ttoweb

cagri_haberi

The Innovative Medicines Initiative (IMI) has launched IMI2 – Call 13.

Stage 1 submission deadline: 28 February 2018
Stage 2 submission deadline: 06 September 2018

Proposals must be submitted via the electronic submission system of the Horizon 2020 Participant Portal.

Detailed information: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/h2020-jti-imi2-2017-13-two-stage.html

If you want to apply to take part in a new IMI project, you need to find or build an applicant consortium, and to do this, you will need to find partners.

https://www.imi.europa.eu/content/partner-search page provides some tips on how to go about this.

Open call topics:
• IMI2-2017-13-01: Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
• IMI2-2017-13-02: Genome-Environment Interactions in Inflammatory Skin Disease
• IMI2-2017-13-03: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
• IMI2-2017-13-04: Mitochondrial Dysfunction in Neurodegeneration
• IMI2-2017-13-05: Support and coordination action for the projects of the Neurodegeneration area of the Innovative Medicines Initiative
• IMI2-2017-13-06: A sustainable European induced pluripotent stem cell platform
• IMI2-2017-13-07: Linking digital assessment of mobility to clinical endpoints to support regulatory acceptance and clinical practice
• IMI2-2017-13-08: Human Tumour Microenvironment Immunoprofiling
• IMI2-2017-13-09: ConcePTION – Continuum of Evidence from Pregnancy Exposures, Reproductive Toxicology and Breastfeeding to Improve Outcomes Now
• IMI2-2017-13-10: Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
• IMI2-2017-13-11: Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
• IMI2-2017-13-12: Pilot programme on a Clinical Compound Bank for Repurposing: Cardiovascular diseases and diabetes
• IMI2-2017-13-13: Pilot programme on a Clinical Compound Bank for Repurposing: Respiratory diseases
• IMI2-2017-13-14: Pilot programme on a Clinical Compound Bank for Repurposing: Neurodegenerative diseases
• IMI2-2017-13-15: Pilot programme on a Clinical Compound Bank for Repurposing: Rare/orphan diseases

Call
Similar posts
  • IDEoPOP Project Receives Grant from Horizon Europe — Bilkent University is a beneficiary of IDEoPOP, a HORIZON-MSCA-2023-DN-01-01 project funded with over 2,4 million €, in which 13 partners participate and is coordinated by Albert-Ludwigs-Universität Freiburg in Germany. Prof. Pınar Bilgin from the Departments of International Relations, and Political Science and Public Administration is leading the training and research team at Bilkent University. The [...]
  • BIDEB International Fellowships — TUBITAK BIDEB announced “2219- International Postdoctoral Research Fellowship” and “2214/A- International Research Fellowship (for PhD Students)” Programs 2021 application periods. Applications will be accepted via https://e-bideb.tubitak.gov.tr/giris.htm web site. Application Period: 29/03/2021-28/06/2021 2219 Program website: https://tubitak.gov.tr/tr/burslar/doktora-sonrasi/arastirma-burs-programlari/icerik-2219-yurt-disi-doktora-sonrasi-arastirma-burs-programi 2214 Program website: [...]
  • FLAG-ERA 2019 Call — The FLAG-ERA Joint Transnational Call (JTC) 2019 supports research projects in synergy with the two FET Flagships, the Graphene Flagship and the Human Brain Project. It is designed to expand the current Flagships with new research contributing to the Flagship objectives in selected areas. Selected projects are expected to be integrated in the Flagships as [...]
  • International Fellowship for Outstanding Researchers Progra... — The International Fellowship for Outstanding Researchers Program aims to support qualified researchers with leading scientific and/or technological achievements and international work experience to conduct their research in leading academic, industrial or public institutions to contribute in areas that are strategic value to Turkey. The duration of the fellowship is to be between 24 to 36 [...]
  • TUBITAK ARDEB Infoday 21 December 2018 — Please kindly note that an Information Session on “TUBITAK ARDEB Programs Update: 1001, 1002, 1005 and 3501 Programs” will take place at Bilkent University. Our speaker will be Prof.Dr. Feza Korkusuz from Tübitak and the language will be Turkish. The session will take place on 21 December 2018 13:40 at UNAM Conference Room. [...]

Archives